BioInvent International AB
STO:BINV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
BioInvent International AB
STO:BINV
|
SE |
|
M
|
Mitsui High-tec Inc
OTC:MHTCF
|
JP |
|
Mojave Brands Inc
F:0HC
|
CA |
|
M
|
Murata Manufacturing Co Ltd
XMUN:MUR1
|
JP |
|
Z
|
Ziprecruiter Inc
XMUN:47R
|
US |
|
Telkom Indonesia (Persero) Tbk PT
F:PTI
|
ID |
|
N
|
Novo Nordisk A/S
OTC:NONOF
|
DK |
|
H
|
Harim Co Ltd
KOSDAQ:136480
|
KR |
|
N
|
Next PLC
DUS:NXG
|
UK |
|
A
|
Archer-Daniels-Midland Co
F:ADM
|
US |
|
E
|
Epack Durable Ltd
NSE:EPACK
|
IN |
|
B
|
BIOAGE Labs Inc
NASDAQ:BIOA
|
US |
|
Copenhagen Airports A/S
CSE:KBHL
|
DK |
|
Mogotes Metals Inc
F:OY4
|
CA |
|
P
|
Pinnacle West Capital Corp
DUS:PWC
|
US |
|
L
|
Lenovo Group Ltd
OTC:LNVGF
|
CN |
Bankruptcy Probability
BioInvent International AB's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
BioInvent International AB Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SE |
B
|
BioInvent International AB
STO:BINV
|
1.4B SEK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
505.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
244.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
197.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
134.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
85.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
84.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
88.4B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
61B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
49.8B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
40.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
BioInvent International AB's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, BioInvent International AB has total debt of 1.2m SEK. This includes both short-term (0 SEK) and long-term (1.2m SEK) debt.
You can find a full breakdown on its Balance Sheet.